Thought Leadership
FDA’s Emergency Use Authorizations: Aggressive Action Taken to Combat COVID-19
April 20, 2020
Chad Landmon
Contract Pharma

Axinn partner Chad Landmon co-authored the Contract Pharma article, "FDA’s Emergency Use Authorizations: Aggressive Action Taken to Combat COVID-19."

Click here to access the article. 

By using the Axinn, Veltrop & Harkrider LLP website with cookies enabled on your browser, you agree to our use of cookies during your browsing experience. Learn more about our privacy policy.